We are live on ! Find out more
TARO

Taro Pharmaceutical Industries Ltd.
TARO

Delisted

TARO was delisted on the 21st of June, 2024.

Back to rankings

159 hedge funds and large institutions have $1.02B invested in Taro Pharmaceutical Industries Ltd. in 2016 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 84 increasing their positions, 33 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

485% more call options, than puts

Call options by funds: $6.99M | Put options by funds: $1.19M

155% more repeat investments, than reductions

Existing positions increased: 84 | Existing positions reduced: 33

24% more capital invested

Capital invested by funds: $826M → $1.02B (+$199M)

5% less funds holding

Funds holding: 167 → 159 (-8)

16% less first-time investments, than exits

New positions opened: 26 | Existing positions closed: 31

38% less funds holding in top 10

Funds holding in top 10: 8 → 5 (-3)

Holders
159
Holders Change
-8
Holders Change %
-4.79%
% of All Funds
4.24%
Holding in Top 10
5
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-37.5%
% of All Funds
0.13%
New
26
Increased
84
Reduced
33
Closed
31
Calls
$6.99M
Puts
$1.19M
Net Calls
+$5.79M
Net Calls Change
+$6.04M

Top Buyers

1
Goldman Sachs
Goldman Sachs
New York
+$40.6M
2
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$20.1M
3
Renaissance Technologies
Renaissance Technologies
New York
+$18.4M
4
BIT
BlackRock Institutional Trust
California
+$15.2M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$14.9M

Top Sellers

1
GCM
Greywolf Capital Management
New York
-$35.1M
2
AllianceBernstein
AllianceBernstein
Tennessee
-$8.62M
3
GPC
Guardian Point Capital
Virginia
-$7.16M
4
Morgan Stanley
Morgan Stanley
New York
-$5.21M
5
AL
AJO LP
Pennsylvania
-$4.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
Walleye Trading
151
Walleye Trading
New York
$9K +$8.79K +62 New
CLOS
152
Compagnie Lombard Odier SCmA
Switzerland
$7K -$7.09K -50 -50%
FWM
153
Focused Wealth Management
New York
$5K – – –
S
154
SignatureFD
Georgia
$3K -$284 -2 -8%
GBBWRPM
155
Genovese Burford & Brothers Wealth & Retirement Plan Management
California
$3K – – –
SAMC
156
Shinko Asset Management Company
Japan
$3K – – –
WTB
157
Washington Trust Bank
Washington
$2K – – –
QCG
158
Quadrant Capital Group
Ohio
$2K +$2.55K +18 +129%
GT
159
Glenmede Trust
Pennsylvania
$2K +$2.84K +20 New
GCM
160
Greywolf Capital Management
New York
– -$35.1M -244,686 Closed
GPC
161
Guardian Point Capital
Virginia
– -$7.16M -50,000 Closed
AL
162
AJO LP
Pennsylvania
– -$4.5M -31,429 Closed
Millennium Management
163
Millennium Management
New York
– -$4.31M -30,114 Closed
MCP
164
Moab Capital Partners
New York
– -$4.3M -30,007 Closed
KA
165
Kerrisdale Advisers
Florida
– -$3.96M -27,615 Closed
CHAM
166
Clear Harbor Asset Management
Connecticut
– -$3.25M -22,705 Closed
HHC
167
Hutchin Hill Capital
New York
– -$3.15M -22,000 Closed
CCMG
168
Clark Capital Management Group
Pennsylvania
– -$2.97M -20,699 Closed
AI
169
Analytic Investors
California
– -$2.2M -15,368 Closed
ARTA
170
A.R.T. Advisors
New York
– -$1.94M -13,555 Closed
LP
171
LMR Partners
United Kingdom
– -$1.24K -8,620 Closed
Arrowstreet Capital
172
Arrowstreet Capital
Massachusetts
– -$1.17M -8,137 Closed
Marshall Wace
173
Marshall Wace
United Kingdom
– -$829K -5,787 Closed
Janney Montgomery Scott
174
Janney Montgomery Scott
Pennsylvania
– -$802K -5,600 Closed
AIM
175
Assured Investment Management
New York
– -$797K -5,566 Closed
4 5 6
7
8

TARO Hedge Fund Activity: Q2 2016 in Review

159 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Taro Pharmaceutical Industries Ltd. (TARO) for Q2 2016, worth a combined $1.02B — up 24% from $826M a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of TARO and 26 opened new positions — a net loss of 5 holders — while 33 trimmed existing stakes and 84 added.

The largest buyer was Goldman Sachs, adding an estimated $40.6M. The largest seller was Greywolf Capital Management, exiting entirely with an estimated $35.1M sold.

  • 159 institutional investors held Taro Pharmaceutical Industries Ltd. (TARO) as of Q2 2016, down from 167 in Q1 2016.
  • Funds reported $1.02B of Taro Pharmaceutical Industries Ltd. stock for Q2 2016, up 24% quarter-over-quarter.
  • 26 funds opened new Taro Pharmaceutical Industries Ltd. positions in Q2 2016 and 31 closed out, a net change of -5 holders.
  • The largest Taro Pharmaceutical Industries Ltd. buyer in Q2 2016 was Goldman Sachs, an estimated $40.6M added.
  • The largest Taro Pharmaceutical Industries Ltd. seller in Q2 2016 was Greywolf Capital Management, an estimated $35.1M sold.

Based on aggregated 13F filings for Q2 2016.